Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Omics Approaches in Pancreatic Adenocarcinoma.
González-Borja I, Viúdez A, Goñi S, Santamaria E, Carrasco-García E, Pérez-Sanz J, Hernández-García I, Sala-Elarre P, Arrazubi V, Oyaga-Iriarte E, Zárate R, Arévalo S, Sayar O, Vera R, Fernández-Irigoyen J. González-Borja I, et al. Among authors: sala elarre p. Cancers (Basel). 2019 Jul 25;11(8):1052. doi: 10.3390/cancers11081052. Cancers (Basel). 2019. PMID: 31349663 Free PMC article. Review.
Counterpoint: Weighing the Risks and Benefits of Neoadjuvant Therapy in Resectable Pancreatic Cancer. Neoadjuvant Therapy Should Not Be Used as Part of Standard Clinical Practice.
Elarre PS, Yu KH. Elarre PS, et al. Oncology (Williston Park). 2018 Jan 15;32(1):39, 42-4. Oncology (Williston Park). 2018. PMID: 29447421 Free article. No abstract available.
Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse.
Sala Elarre P, Oyaga-Iriarte E, Yu KH, Baudin V, Arbea Moreno L, Carranza O, Chopitea Ortega A, Ponz-Sarvise M, Mejías Sosa LD, Rotellar Sastre F, Larrea Leoz B, Iragorri Barberena Y, Subtil Iñigo JC, Benito Boíllos A, Pardo F, Rodríguez Rodríguez J. Sala Elarre P, et al. Cancers (Basel). 2019 Apr 30;11(5):606. doi: 10.3390/cancers11050606. Cancers (Basel). 2019. PMID: 31052270 Free PMC article.
Feedback